-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from 2016 to Q1 2025.
- Autolus Therapeutics plc Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$75.6M, a 86.5% decline year-over-year.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$206M, a 41.7% decline from 2023.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$146M, a 29.6% decline from 2022.
- Autolus Therapeutics plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$112M, a 4.71% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)